Totally implantable venous access devices (TVAD) are commonly used to supply long-term, intermittent central venous access for the administration of chemotherapeutic drugs and intravenous (IV) antibiotics (1, 2). The most common complications related to TVAD implantation are venous thrombosis, extravasation, dislodgement, catheter leakage, and infection. Fracture and embolization of TVAD and re...
